Literature DB >> 33217515

Microglial circadian clock regulation of microglial structural complexity, dendritic spine density and inflammatory response.

Hiroshi Nakanishi1, Junjun Ni2, Saori Nonaka3, Yoshinori Hayashi4.   

Abstract

Cortical microglia exhibit a ramified shape during sleep, while they have a hyper-ramified shape during wakefulness, which is characterized by their longer processes with increased branching points. The microglial molecular circadian clock regulates expressions of both cathepsin S (CatS) and P2Y12 receptors in the brain with a peak at zeitgeber time 14 (2 h after beginning of the dark phase). We postulated that these two microglia-specific molecules contribute to diurnal alterations of microglial shapes and neuronal activities in the cerebral cortex. During wakefulness, CatS secreted from cortical microglia may be involved in P2Y12 receptor-dependent process extension. Secreted CatS subsequently degrades the perineuronal nets, initiating the downscaling of both spine density and synaptic strength of cortical neurons toward the beginning of sleep. The downscaling of both spine density and synaptic strength of cortical neurons during sleep could improve signal-to-noise, which would benefit memory consolidation, or allow for new learning to occur during subsequent waking. Furthermore, disruption of CatS induces the sleep disturbance and impaired social interaction in mice. Moreover, the microglial clock system disruption may also play a role in the early pathogenesis of Alzheimer's disease. The reduced expression of BMAL1 in cortical microglia caused by oligomeric amyloid β may induce the increased presence of inflammatory phenotype through a reduction in RORα, which in turn reduced IκBα and enhanced NF-κB activation. These observations suggest that the microglial clock system disruption contribute to pathogeneses of sleep disturbance, impaired social interaction and cognitive impairment. Therefore, the growing understanding of the microglial circadian molecular clock might aid in the development of novel pharmacological interventions against both neuropsychiatric and neurodegenerative disorders.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Alzheimer's disease; Cathepsin S; Clock genes; Microglia; Neuroinflammation; P2Y12 receptors

Year:  2020        PMID: 33217515     DOI: 10.1016/j.neuint.2020.104905

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  6 in total

Review 1.  Control of complex behavior by astrocytes and microglia.

Authors:  P I Ortinski; K J Reissner; J Turner; T A Anderson; A Scimemi
Journal:  Neurosci Biobehav Rev       Date:  2022-04-01       Impact factor: 9.052

Review 2.  Synapses, Microglia, and Lipids in Alzheimer's Disease.

Authors:  Patrick J Paasila; Jason A Aramideh; Greg T Sutherland; Manuel B Graeber
Journal:  Front Neurosci       Date:  2022-01-12       Impact factor: 4.677

3.  Cortical diurnal rhythms remain intact with microglial depletion.

Authors:  Rocio A Barahona; Samuel Morabito; Vivek Swarup; Kim N Green
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

4.  Melatonin ameliorates Parkinson's disease via regulating microglia polarization in a RORα-dependent pathway.

Authors:  Jingwen Li; Hanshu Liu; Xinyi Wang; Yun Xia; Jinsha Huang; Tao Wang; Zhicheng Lin; Nian Xiong
Journal:  NPJ Parkinsons Dis       Date:  2022-07-08

Review 5.  Tumor-Associated Microenvironment of Adult Gliomas: A Review.

Authors:  Vincenzo Di Nunno; Enrico Franceschi; Alicia Tosoni; Lidia Gatto; Stefania Bartolini; Alba Ariela Brandes
Journal:  Front Oncol       Date:  2022-07-07       Impact factor: 5.738

6.  Circadian nuclear receptor Rev-erbα is expressed by platelets and potentiates platelet activation and thrombus formation.

Authors:  Jianfeng Shi; Renyang Tong; Meng Zhou; Yu Gao; Yichao Zhao; Yifan Chen; Wenhua Liu; Gaoxiang Li; Dong Lu; Guofeng Meng; Liuhua Hu; Ancai Yuan; Xiyuan Lu; Jun Pu
Journal:  Eur Heart J       Date:  2022-06-21       Impact factor: 35.855

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.